Financial Performance Summary

Q2 FY2027 Performance (Consolidated)

  • Revenue from Contracts with Customers: ₹7,836 million, representing 21.2% YoY growth (vs. ₹6,467 million in Q2 FY2026)
  • Inventory and Data Costs: ₹4,896 million (23.6% YoY growth)
  • Employee Benefits Expenses: ₹663 million (4.9% YoY growth)
  • Other Expenses: ₹463 million (11.8% YoY growth)
  • EBITDA: ₹1,814 million (24.2% YoY growth)
  • EBITDA Margin: 23.2% (vs. 22.6% in Q2 FY2026)
  • Depreciation and Amortisation Expenses: ₹412 million (29.3% YoY growth)
  • Finance Costs: ₹8 million (29.5% decrease YoY)
  • Other Income: ₹200 million (10.0% decrease YoY)
  • Profit Before Tax: ₹1,595 million (17.8% YoY growth)
  • Total Tax: ₹297 million (19.5% YoY growth)
  • Profit After Tax: ₹1,298 million (17.4% YoY growth)
  • PAT Margin: 16.2% (vs. 16.5% in Q2 FY2026)
  • Effective Tax Rate: 18.6% (vs. 18.3% in Q2 FY2026)

Half Yearly FY2027 Performance (Consolidated)

  • Revenue from Contracts with Customers: ₹15,308 million, representing 20.8% YoY growth (vs. ₹12,675 million in H1 FY2026)
  • Inventory and Data Costs: ₹9,618 million (24.2% YoY growth)
  • Employee Benefits Expenses: ₹1,319 million (4.6% YoY growth)
  • Other Expenses: ₹879 million (5.4% YoY growth)
  • EBITDA: ₹3,491 million (22.1% YoY growth)
  • EBITDA Margin: 22.8% (vs. 22.6% in H1 FY2026)
  • Profit After Tax: ₹2,582 million (19.5% YoY growth)
  • PAT Margin: 16.4% (vs. 16.5% in H1 FY2026)
  • Effective Tax Rate: 18.6% (vs. 18.3% in H1 FY2026)

Business Model and Operational Metrics

  • Cost Per Converted User (CPCU) business model contributed 99.8% of Revenue from Contracts with Customers in H1 FY2027
  • Global reach across 4 billion+ connected devices (for the 12-month period ending September 30, 2026)
  • Revenue split: 27.0% from India & Emerging Markets, 73.0% from Developed Markets in H1 FY2027
  • Vertical focus on high-growth categories: E-Governance, F-Healthcare, G-Travel & Mobility, H-Home & Other Utilities
  • Total 40 unique patents with 18 granted and 22 filed & pending across jurisdictions
  • Data Protection Trustmark certified and ISO 27001:2022 certified

Case Studies and Client Performance

Orange Health Labs (Healthcare, India)

  • Campaign period: July 26 - September 26, 2026
  • 53% uplift in purchases (Q2 FY27 vs Q1 FY27)
  • 39% revenue growth (Q2 FY27 vs Q1 FY27)
  • Share of voice increased by 2X (Q2 FY27 vs Q1 FY27)

JBL (Audio, India)

  • Campaign period: July 26 - September 26, 2026
  • 95% video completion rate among high-intent households
  • 40% click-to-visit rate
  • 3.5X higher mobile CTR after first week of CTV exposure

CrazyGames (Gaming, US)

  • Campaign period: July 26 - September 26, 2026
  • 2x increase in total revenue (September 2026 vs January 2026)
  • >200% lift in repeat ad revenue event conversions
  • Conversion rate rose by 1.8X (September 2026 vs January 2026)

Shareholding and Corporate Actions

  • During Q2 FY2027, 34,964 shares were allotted to Affle Holdings Pte. Ltd. on August 14, 2026, on receipt of warrant conversion request
  • Listing approval for these shares received on October 27, 2026
  • Company has further allotted 1,704,324 equity shares on October 19, 2026 and 1,277,155 equity shares on October 21, 2026, on receipt of request from Affle Holdings Pte. Ltd. for conversion of equal number of warrants
  • Company is in process of applying for listing and trading of these additional shares

Forward-looking Statements Disclaimer

The presentation contains forward-looking statements based on management's current views and assumptions, involving known and unknown risks and uncertainties that may cause actual results to differ materially.